This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Chr. Hansen Holding Gestione

Gestione criteri di controllo 4/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Mauricio Graber

Amministratore delegato

€3.2m

Compenso totale

Percentuale dello stipendio del CEO	31.3%
Mandato del CEO	5yrs
Proprietà del CEO	0.02%
Durata media del management	5.7yrs
Durata media del Consiglio di amministrazione	4.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Mauricio Graber rispetto agli utili di Chr. Hansen Holding?
Data	Compenso totale	Stipendio	Guadagni aziendali
Feb 28 2023	n/a	n/a	€229m
Nov 30 2022	n/a	n/a	€228m
Aug 31 2022	€3m	€1m	€225m
May 31 2022	n/a	n/a	€230m
Feb 28 2022	n/a	n/a	€221m
Nov 30 2021	n/a	n/a	€209m
Aug 31 2021	€3m	€986k	€199m
May 31 2021	n/a	n/a	€199m
Feb 28 2021	n/a	n/a	€213m
Nov 30 2020	n/a	n/a	€222m
Aug 31 2020	€3m	€969k	€232m
May 31 2020	n/a	n/a	€218m
Feb 29 2020	n/a	n/a	€221m
Nov 30 2019	n/a	n/a	€224m
Aug 31 2019	€3m	€953k	€229m
May 31 2019	n/a	n/a	€246m
Feb 28 2019	n/a	n/a	€240m
Nov 30 2018	n/a	n/a	€233m
Aug 31 2018	€2m	€238k	€228m

Compensazione vs Mercato: Mauricio's total compensation ($USD3.45M) is about average for companies of similar size in the MX market ($USD2.75M).

Compensazione vs guadagni: Mauricio's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Mauricio Graber (60 yo)

5yrs

Mandato

€3,209,000

Compensazione

Mr. Mauricio Graber has been Chief Executive Officer, President and Member of Executive Board of Chr. Hansen Holding A/S since joining it on June 1, 2018. Mr. Graber serves as Director of Jungbunzlauer Sui...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Mauricio Graber	CEO, President & Member of Executive Board	5yrs	€3.21m	0.024% € 39.0m
Lise Mortensen	Executive VP	2.7yrs	€1.32m	0.0021% € 3.5m
Thomas Schafer	Chief Science Advisor	1.3yrs	€1.58m	Nessun dato
Torsten Steenholt	Executive Vice President of Global Operations	6.4yrs	Nessun dato	Nessun dato
Henrik Nielsen	Executive VP & Chief Scientific Officer	1.2yrs	Nessun dato	Nessun dato
Anders Christensen	Vice President Group Strategy & Investor Relations	no data	Nessun dato	Nessun dato
Winnie Bugel	Executive Vice President of Compliance & Corporate Affairs	7yrs	Nessun dato	Nessun dato
Sanne Seyer-Hansen	Head of Media Relations	no data	Nessun dato	Nessun dato
Alice Larsen	Executive Vice President of Human Resources	6.9yrs	Nessun dato	Nessun dato
Laurent Hubert	VP & Head of Food	no data	Nessun dato	Nessun dato
Jacob Paulsen	Executive Vice President of Food Cultures & Enzymes	6.8yrs	Nessun dato	Nessun dato
Christian Barker	Executive Vice President of Health & Nutrition	no data	Nessun dato	Nessun dato

5.7yrs

Durata media

55yo

Età media

Gestione esperta: CHR N's management team is seasoned and experienced (5.7 years average tenure).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jesper Brandgaard	Independent Vice Chairman	5.6yrs	€154.00k	0.0035% € 5.8m
Dominique J. Reiniche	Independent Chairman of the Board	9.6yrs	€266.00k	0.0019% € 3.1m
Luis Rocamora	Independent Director	6.6yrs	€116.00k	0.0017% € 2.8m
Kasim Kutay	Representative Non Independent Director	less than a year	Nessun dato	Nessun dato
Heidi Kleinbach-Sauter	Independent Director	5.6yrs	€107.00k	0.00065% € 1.1m
Heine Dalsgaard	Representative Non Independent Director	less than a year	Nessun dato	Nessun dato
Charlotte Hemmingsen	Employee Representative Director	5.6yrs	€59.00k	0.00086% € 1.4m
Kim Soerensen	Employee Representative Director	5.6yrs	€59.00k	0.000080% € 132.5k
Kevin Lane	Independent Director	2.6yrs	€109.00k	0.00076% € 1.3m
Lise Kaae	Independent Director	2.6yrs	€105.00k	0.0010% € 1.7m
Casper Giedo	Employee Representative Director	1.6yrs	€45.00k	0.000020% € 33.1k
Karen Lauesen	Employee Representative Director	1.6yrs	€45.00k	0.000040% € 66.2k

4.1yrs

Durata media

58.5yo

Età media

Consiglio di amministrazione esperto: CHR N's board of directors are considered experienced (4.1 years average tenure).

This company is no longer active

Chr. Hansen Holding Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Executive VP recently bought Mex$1.5m worth of stock

Key Executive recently bought Mex$135k worth of stock

High number of new directors

High number of new directors

High number of new directors

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Executive VP recently bought Mex$1.5m worth of stock

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Key Executive recently bought Mex$135k worth of stock

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

High number of new directors

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

High number of new directors

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media